- Home
- HLMN vs MYGN Comparison
HLMN vs MYGN Comparison
Compare HLMN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLMN
- MYGN
- Stock Information
- Founded
- HLMN 1964
- MYGN 1991
- Country
- HLMN United States
- MYGN United States
- Employees
- HLMN N/A
- MYGN N/A
- Industry
- HLMN Industrial Machinery/Components
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HLMN Consumer Discretionary
- MYGN Health Care
- Exchange
- HLMN Nasdaq
- MYGN Nasdaq
- Market Cap
- HLMN 2.2B
- MYGN 2.0B
- IPO Year
- HLMN N/A
- MYGN 1995
- Fundamental
- Price
- HLMN $9.38
- MYGN $13.50
- Analyst Decision
- HLMN Buy
- MYGN Hold
- Analyst Count
- HLMN 6
- MYGN 11
- Target Price
- HLMN $14.20
- MYGN $24.27
- AVG Volume (30 Days)
- HLMN 990.7K
- MYGN 1.1M
- Earning Date
- HLMN 02-20-2025
- MYGN 02-25-2025
- Dividend Yield
- HLMN N/A
- MYGN N/A
- EPS Growth
- HLMN N/A
- MYGN N/A
- EPS
- HLMN 0.04
- MYGN N/A
- Revenue
- HLMN $1,470,841,000.00
- MYGN $823,600,000.00
- Revenue This Year
- HLMN $1.80
- MYGN $13.82
- Revenue Next Year
- HLMN $4.72
- MYGN $4.59
- P/E Ratio
- HLMN $250.44
- MYGN N/A
- Revenue Growth
- HLMN N/A
- MYGN 12.15
- 52 Week Low
- HLMN $8.43
- MYGN $12.87
- 52 Week High
- HLMN $12.08
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- HLMN 24.95
- MYGN 32.61
- Support Level
- HLMN $9.56
- MYGN $13.04
- Resistance Level
- HLMN $10.02
- MYGN $13.77
- Average True Range (ATR)
- HLMN 0.32
- MYGN 0.60
- MACD
- HLMN -0.11
- MYGN 0.14
- Stochastic Oscillator
- HLMN 2.30
- MYGN 24.51
About HLMN Hillman Solutions Corp.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.